DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,030,326,545 | +10.1% | 8,183,501 | +6.5% | 0.45% | +15.2% |
| Q2 2023 | $1,843,351,851 | -1.7% | 7,680,633 | +3.2% | 0.39% | -5.6% |
| Q1 2023 | $1,875,280,940 | +6.6% | 7,440,410 | +12.3% | 0.41% | +2.0% |
| Q4 2022 | $1,759,186,475 | -3.5% | 6,627,935 | -6.1% | 0.40% | -9.0% |
| Q3 2022 | $1,822,744,000 | +1.9% | 7,056,978 | +0.0% | 0.44% | +8.1% |
| Q2 2022 | $1,788,790,000 | -11.3% | 7,055,817 | +2.7% | 0.41% | +4.6% |
| Q1 2022 | $2,015,691,000 | -12.2% | 6,871,750 | -1.5% | 0.39% | -5.6% |
| Q4 2021 | $2,294,475,000 | +8.4% | 6,973,876 | +0.3% | 0.41% | +0.2% |
| Q3 2021 | $2,117,282,000 | +14.6% | 6,954,668 | +1.0% | 0.41% | +15.7% |
| Q2 2021 | $1,847,728,000 | +26.7% | 6,885,266 | +6.3% | 0.36% | +19.8% |
| Q1 2021 | $1,458,572,000 | +10.2% | 6,480,237 | +8.7% | 0.30% | +3.5% |
| Q4 2020 | $1,323,882,000 | +10.8% | 5,959,673 | +7.4% | 0.29% | -2.4% |
| Q3 2020 | $1,194,559,000 | +26.6% | 5,547,579 | +4.0% | 0.30% | +17.1% |
| Q2 2020 | $943,593,000 | +30.1% | 5,336,163 | +1.8% | 0.25% | +5.0% |
| Q1 2020 | $725,218,000 | -14.6% | 5,239,639 | -5.3% | 0.24% | +9.6% |
| Q4 2019 | $849,563,000 | +0.8% | 5,535,342 | -5.2% | 0.22% | -5.2% |
| Q3 2019 | $842,881,000 | +2.5% | 5,835,915 | +1.4% | 0.23% | +3.1% |
| Q2 2019 | $822,255,000 | +11.9% | 5,753,246 | +3.4% | 0.22% | +8.7% |
| Q1 2019 | $734,624,000 | +28.7% | 5,564,494 | +0.5% | 0.21% | +15.1% |
| Q4 2018 | $570,694,000 | +1.8% | 5,534,269 | +7.3% | 0.18% | +24.3% |
| Q3 2018 | $560,662,000 | +9.6% | 5,159,780 | -0.4% | 0.14% | +3.6% |
| Q2 2018 | $511,320,000 | +0.1% | 5,181,609 | -0.7% | 0.14% | -1.4% |
| Q1 2018 | $510,746,000 | +0.2% | 5,216,493 | -5.0% | 0.14% | +5.2% |
| Q4 2017 | $509,582,000 | +6.4% | 5,490,006 | -1.7% | 0.13% | +1.5% |
| Q3 2017 | $478,977,000 | -16.0% | 5,583,785 | -17.4% | 0.13% | -18.0% |
| Q2 2017 | $570,482,000 | -12.8% | 6,760,084 | -11.6% | 0.16% | -11.0% |
| Q1 2017 | $653,946,000 | +10.6% | 7,645,818 | +0.7% | 0.18% | +6.5% |
| Q4 2016 | $591,205,000 | +7.5% | 7,595,145 | +8.2% | 0.17% | +3.7% |
| Q3 2016 | $550,086,000 | -17.2% | 7,017,297 | +6.7% | 0.16% | -19.2% |
| Q2 2016 | $664,120,000 | +3.0% | 6,575,437 | -3.2% | 0.20% | +4.1% |
| Q1 2016 | $644,635,000 | +0.0% | 6,795,659 | -2.1% | 0.20% | 0.0% |
| Q4 2015 | $644,561,000 | +3.7% | 6,939,709 | -4.9% | 0.20% | +2.1% |
| Q3 2015 | $621,856,000 | -1.2% | 7,294,774 | -0.8% | 0.19% | +10.4% |
| Q2 2015 | $629,155,000 | -3.5% | 7,350,791 | -4.3% | 0.17% | +1.8% |
| Q1 2015 | $652,167,000 | -3.4% | 7,677,621 | -2.5% | 0.17% | -3.4% |
| Q4 2014 | $674,998,000 | +11.2% | 7,871,405 | -1.5% | 0.18% | +6.7% |
| Q3 2014 | $607,141,000 | -54.5% | 7,990,794 | -52.9% | 0.16% | -8.3% |
| Q2 2014 | $1,335,752,000 | +111.2% | 16,966,240 | +101.2% | 0.18% | +4.7% |
| Q1 2014 | $632,348,000 | -3.8% | 8,431,274 | -1.0% | 0.17% | -6.0% |
| Q4 2013 | $657,634,000 | -46.6% | 8,518,575 | -52.1% | 0.18% | -1.1% |
| Q3 2013 | $1,232,500,000 | +135.4% | 17,779,858 | +115.0% | 0.18% | +12.1% |
| Q2 2013 | $523,551,000 | +2908516.7% | 8,270,953 | +2432533.2% | 0.16% | +816.7% |
| Q2 2011 | $18,000 | – | 340 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |